| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.035 | 0.9 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.041 | 0.9 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.0066 | 0.9 |